Anti-claudin 18.2 antibodies and uses thereof

• 收藏
• 分享

专利权人:

Lanova Medicines Limited Company

发明人:

LI, Runsheng

申请号：

AU2019270865

公开号：

AU2019270865A1

申请日:

2019.05.20

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Provided are antibodies or fragment thereof having binding specificity to the wild-type human claudin 18.2 (CLDN18.2) protein and also capable of binding the M149L mutant. By contrast, such antibodies and fragments do not or weakly bind to claudin 18.1 (CLDN18.1).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/